Kawano, Y., Ohyanagi, F., Yanagitani, N., Kudo, K., Horiike, A., Tanimoto, A., Nishizawa, H., Ichikawa, A., Sakatani, T., Nakatomi, K., Hagiwara, S., Ninomiya, H., Motoi, N., Ishikawa, Y., Horai, T. and Nishio, M. (2013) Pemetrexed and Cisplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer in Japanese Patients: Phase II Study. Anticancer Research, 33, 3327-3333.

has been cited by the following article:

• TITLE: The Outcome of the Chemotherapy and Oncothermia for Far Advanced Adenocarcinoma of the Lung: Case Reports of Four Patients

  AUTHORS: Doo Yun Lee, Joon Seok Park, Hae Chul Jung, Eun Seol Byun, Seok Jin Haam, Sung Soo Lee

  KEYWORDS: Lung Cancer, Chemotherapy

  JOURNAL NAME: Advances in Lung Cancer, Vol.4 No.1, March 13, 2015

  ABSTRACT: Lung cancer is one of the most aggressive and lethal form of cancers. Patients with far advanced lung cancer are treated by chemotherapy with or without radiotherapy. However, median survival of these patients is less than 6 months. To increase survival and quality of life for these patients, various forms of complementary treatments have been tried in clinical practices, and oncothermia is supposed to be one of the promising candidates. From May 2008 to November 2013, 4 patients with far advanced lung adenocarcinoma (stages IIIB and IV) were treated with oncothermia in addition to conventional chemotherapy at Gangnam Severance Hospital and Bundang CHA Hospital. All these patients have survived for more than 2 years.